New to Bioss? Enjoy 35% of your first order. Use code "FirstOrder35" - Offer valid for new U.S. Customers on direct orders only

FG-4592 (Roxadustat), HIF Prolyl-Hydroxylases Inhibitor

Overview
Catalog # bs-60263c-2-mg-solid
Product Name FG-4592 (Roxadustat), HIF Prolyl-Hydroxylases Inhibitor
Specifications
Storage Buffer Powder
Storage Condition Store in dry, dark place at -20C for 1 year.
Target
Product Information Molecular Weight: 352.34

Formula: C19 H16 N2 O5

CAS Number: 808118-40-3

InChi Key: YOZBGTLTNGAVFU-UHFFFAOYSA-N

InChi: InChI=1S/C19H16N2O5/c1-11-15-9-13(26-12-5-3-2-4-6-12)7-8-14(15)18(24)17(21-11)19(25)20-10-16(22)23/h2-9,24H,10H2,1H3,(H,20,25)(H,22,23)

Smiles: CC1=NC(C(=O)NCC(O)=O)=C(O)C2=CC=C(C=C21)OC1C=CC=CC=1

Purity: 98.0

Solubility: DMSO up to 50 mM

Appearance: Solid Power.

Shelf Life: 1.0 years
Description FG-4592 (Roxadustat) is a potent, selective and bioavailable inhibitor of hypoxia-inducible factor prolyl hydroxylase. It is an analog of 2-oxoglutarate (2-OG) to inhibit HIF-PH and prevent HIF turnover. While little has been published regarding the actions of this compound, similar HIF-PH inhibitors suppress HIF degradation and in this way induce erythropoietin expression, promoting erythropoiesis or preventing anemia in vivo. Right now FG-4592 is in phase III clinical trials to treat anemia.